[243 Pages Report] The global deflectable catheters market is projected to expand at a CAGR of 3.9% from 2022 to 2029. Sales of deflectable catheters currently stand at a valuation of US$ 1.8 Billion, and are estimated to reach a market valuation of US$ 2.4 Billion by 2029.
| Attribute | Details |
|---|---|
| Deflectable Catheters Market Size (2022) | US$ 1.8 Billion |
| Projected Market Value (2029) | US$ 2.4 Billion |
| Estimated Market Growth Rate (2022 to 2029) | 3.9% CAGR |
| Market Share of Hospitals (2022) | 54.7% |
Shipments of deflectable catheters account for a 9.8% revenue share of the global catheter market. Rising preference for minimally-invasive procedures and high incidence of cardiovascular diseases across the world are expected to be the main factors driving market expansion.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
| Particulars | Details |
|---|---|
| H1, 2021 | 3.91% |
| H1, 2022 Projected | 3.86% |
| H1, 2022 Outlook | 3.26% |
| BPS Change - H1, 2022 (O) - H1, 2022 (P) | (-) 60 ↓ |
| BPS Change – H1, 2022 (O) - H1, 2021 | (-) 65 ↓ |
The comparative analysis and market growth rate of the global deflectable catheters market as studied by Future Market Insights will show a negative BPS growth in the H1-2022 outlook as compared to H1-2022 projected period by 60 BPS, and, a decline in BPS growth is expected in H1-2022 over H1- 2021 duration with 65 Basis Point Share (BPS).
The market is subject to medical device regulations, in accordance with macroeconomic and industrial standards.
The market experienced a decline in the BPS values associated with the inherent device limitations such as its size and limited trackability, and infusion limitations, causing a shift in product preference. Moreover, a large number of reported occurrences of catheter-associated urinary tract infections (CAUTI) have further restrained patient preference towards the product.
However, with the introduction of steerable catheters, the market is likely to observe a positive growth outlook over the forecasted years. The key developments in the market include the introduction of the cobra catheter for complex surgical interventions.
The world has seen a substantial rise in cardiovascular disorders, and this has spawned major demand for multiple cardiovascular treatments. Consumption of deflectable catheters rose at a CAGR of 3.8% from 2014 to 2021.
The increasing prevalence of peripheral artery diseases, growing geriatric population, increasing preference for minimally invasive surgeries, rapid advancements in catheters, and rising number of cardiovascular surgeries are major factors that guide the sales of deflectable catheter systems.
With cardiovascular diseases becoming one of the prime causes of death across the world, demand for better and more effective treatments has also bolstered amidst this. Government initiatives are focusing on increasing awareness of these cardiovascular disorders and investments to further advance research and development of novel treatment products.
Complications associated with the use of catheters, risk of myocardial infections, and allergic reactions are expected to hinder deflectable catheter sales to a certain extent over the forecast period. However, these drawbacks are being addressed by research and the development of better catheters free from the aforementioned risks.
The deflectable catheters industry is projected to progress steadily at a CAGR of 3.9% from 2022 to 2029.
Principal Consultant
“Increasing Prevalence of Cardiovascular Disorders to Boost Sales of Deflectable Catheters”
The world has seen a substantial increase in the incidence of cardiovascular diseases over the past few years which has subsequently influenced the consumption of deflectable catheters. Increasing research and development activity for cardiovascular diseases is propelling demand for innovative products to cover most applications.
“Increasing Availability of Microcatheters”
Microcatheters have seen a substantial rise in popularity recently and are expected to see rapid development over the forecast period as well. The increasing use of microcatheters is majorly influenced by their key characteristics such as 3D navigation and mirrored workability.
With this widening scope of application, investments in the research & development of microcatheters are expected to see a prominent rise through 2029.
As these advanced microcatheters are developed, their scope of use for deflectable catheters is also expected to increase and subsequently drive market potential.
“China & India to Emerge as Highly Rewarding Markets in the Asian Region”
Deflectable catheter demand analysis for regions such as North America, Latin America, Europe, East Asia, South Asia & Pacific, and the Middle East & Africa (MEA) has been discussed in this FMI study.
The North American deflectable catheters market is expected to account for the largest market share and is projected to maintain this stance through 2029. The presence of key deflectable catheter manufacturers and well-established healthcare infrastructure are expected to be prime drivers for deflectable catheter shipments in this region.
The Europe deflectable catheter products market is expected to exhibit steady growth in demand over the forecast period. Rising focus on healthcare, increasing medical research and development activities, and a rising geriatric population is anticipated to be major trends in this region.
Deflectable catheter consumption in the regions of South Asia and East Asia is anticipated to see a substantial increase over the forecast period. The increase in demand for deflectable catheters can be attributed to factors such as developing healthcare infrastructure, increasing prevalence of cardiovascular disorders, and increasing healthcare spending potential. China and India are expected to emerge as prime markets in these regions.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
“Rapidly Developing Healthcare Infrastructure to Provide Lucrative Opportunities for Deflectable Catheter Providers”
India has seen a rise in instances of cardiovascular disorders over the past few years, and this is expected to continue through 2029. Increasing sedentary lifestyles, poor eating habits, rising geriatric population, increasing healthcare spending, and rising popularity of minimally invasive cardiovascular procedures are projected to guide deflectable catheter consumption over the forecast period.
Deflectable catheter manufacturers can focus on India to discover untapped potential in this nation and increase their overall sales revenue.
“Increasing Incidence of Cardiovascular Ailments to Propel Deflectable Catheter Consumption”
The USA has been battling some major health issues over the past few years that have been massively influencing public health trends in the nation. The nation has seen a substantial increase in the prevalence of obesity which has led to a significant increase in cardiovascular disorders.
Increasing healthcare spending, rising availability of treatment options, and increasing preference for minimally invasive surgeries are some major factors that govern demand for deflectable catheters in the USA
“Hospitals Account for Majority of Deflectable Catheter Sales; Demand from Catheterization Labs to Soar Going Forward”
Currently, hospitals account for 54.7% of the global deflectable catheter demand and are anticipated to maintain a dominant stance throughout the forecast period, since most cardiovascular treatment procedures require a hospital setting and the presence of medical professionals. However, sales of deflectable catheters are expected to see a rapid increase as demand from independent catheterization labs increases.
In 2022, independent catheterization labs account for 30.7% of the global deflectable catheter market landscape. The number of independent catheterization labs is increasing and is expected to be a prominent trend through 2029.
Office-based clinics and ambulatory surgical centers hold market shares of 2.2% and 12.5%, respectively, in the global deflectable catheters industry.
The COVID-19 pandemic of 2020 largely influenced healthcare infrastructure on a global scale and reshaped the way we approach public healthcare. As coronavirus infections plagued the world, lockdowns were imposed by multiple nations, and all healthcare institutions were focused on dealing with the widespread pandemic.
Amidst these unpredictable times, focus on other diseases was minimal and this negatively impacted the deflectable catheters market. Sales of deflectable catheters saw a major drop as cardiovascular surgeries were not being performed in the wake of coronavirus infections.
However, deflectable catheter shipments are expected to rise at a slow pace in the post-pandemic era and bring the market into recovery mode with many deflectable catheter manufacturers focusing on expanding their revenue potential to cope with previous losses.
Deflectable catheter providers are investing in enhancing the deflectable functionality of catheters and stents to optimize cardiovascular procedures.
| Attribute | Details |
|---|---|
| Forecast Period | 2022 to 2029 |
| Historical Data Available for | 2014 to 2021 |
| Market Analysis | Units for Volume, US$ Million for Value |
| Key Regions Covered |
|
| Key Countries Covered |
|
| Key Market Segments Covered |
|
| Key Companies Profiled |
|
Deflectable Catheters Market by Product Type:
Deflectable Catheters Market by Application:
Deflectable Catheters Market by End User:
Deflectable Catheters Market by Region:
The global deflectable catheters market is valued at US$ 1.8 Billion in 2022.
Shipments of deflectable catheters are projected to increase at a CAGR of 3.9% from 2022 to 2029.
By 2029, deflectable catheter sales are anticipated to rake in a net worth of US$ 2.4 Billion.
Biosense Webster Inc., Teleflex Incorporated, Boston Scientific Corporation, Biomerics LLC, OSYPKA AG, Abbot, Japan Lifeline Co., CathRx Ltd., and Biotronik SE & Co. KG are key market players that have been profiled in this research.
In 2022, the hospital segment held a mammoth share of 54.7% in the global deflectable catheter industry.
1. Executive Summary | Deflectable Catheters Market
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Market Trends
4. Key Success Factors
5. Global Market - Pricing Analysis
5.1. Regional Pricing Analysis By Product Type
5.2. Pricing Break-up
6. Global Market Demand (in Volume) Analysis 2014 to 2021 and Forecast, 2022 to 2029
6.1. Historical Market Volume (Units) Analysis, 2014 to 2021
6.2. Current and Future Market Volume (Units) Projections, 2022 to 2029
6.2.1. Y-o-Y Growth Trend Analysis
7. Global Market Demand (in Value or Size in US$ Million) Analysis 2014 to 2021 and Forecast, 2022 to 2029
7.1. Historical Market Value (US$ Million) Analysis, 2014 to 2021
7.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2029
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Market Background
8.1. Macro-Economic Factors
8.1.1. Global GDP Growth Outlook
8.1.2. Global Healthcare Industry Market Outlook
8.2. Forecast Factors - Relevance & Impact
8.2.1. Increasing Prevalence of Cardiovascular Disease
8.2.2. Number of Surgical Procedures
8.2.3. Technology Advancement
8.2.4. Reimbursement
8.3. Market Dynamics
8.3.1. Drivers
8.3.2. Restraints
8.3.3. Opportunity Analysis
9. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, by Product Type
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) & Volume Analysis By Product Type, 2014 to 2021
9.3. Current and Future Market Size (US$ Million) & Volume Analysis and Forecast By Product Type, 2022 to 2029
9.3.1. Uni-Directional
9.3.2. Bi-Directional
9.3.3. Multi-Directional
9.4. Market Attractiveness Analysis By Product Type
10. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, by Application
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) Analysis By Application, 2014 to 2021
10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2022 to 2029
10.3.1. Coronary Interventions
10.3.2. Electrophysiology
10.3.3. Diagnostics Imaging
10.3.4. Peripheral Interventions
10.4. Market Attractiveness Analysis By Application
11. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, by End User
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Million) Analysis By End User, 2014 to 2021
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2022 to 2029
11.3.1. Hospitals
11.3.2. Office-Based Clinics
11.3.3. Ambulatory Surgical Centers
11.3.4. Independent Catheterization Labs
11.4. Market Attractiveness Analysis By End User
12. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, by Region
12.1. Introduction
12.2. Historical Market Size (US$ Million) Analysis By Region, 2014 to 2021
12.3. Current Market Size (US$ Million) Analysis and Forecast By Region, 2022 to 2029
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. Middle East and Africa (MEA)
12.3.5. East Asia
12.3.6. South Asia
12.3.7. Oceania
12.4. Market Attractiveness Analysis By Region
13. North America Market Analysis 2014 to 2021 and Forecast 2022 to 2029
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2014 to 2021
13.4. Market Size (US$ Million) Forecast By Market Taxonomy, 2022 to 2029
13.4.1. By Country
13.4.1.1. The USA
13.4.1.2. Canada
13.4.2. By Product Type
13.4.3. By Application
13.4.4. By End User
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Product Type
13.5.3. By Application
13.5.4. By End User
13.6. Drivers and Restraints - Impact Analysis
14. Latin America Market Analysis 2014 to 2021 and Forecast 2022 to 2029
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2014 to 2021
14.4. Market Size (US$ Million) Forecast By Market Taxonomy, 2022 to 2029
14.4.1. By Country
14.4.1.1. Brazil
14.4.1.2. Mexico
14.4.1.3. Rest of Latin America
14.4.2. By Product Type
14.4.3. By Application
14.4.4. By End User
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Product Type
14.5.3. By Application
14.5.4. By End User
14.6. Drivers and Restraints - Impact Analysis
15. Europe Market Analysis 2014 to 2021 and Forecast 2022 to 2029
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2014 to 2021
15.4. Market Size (US$ Million) Forecast By Market Taxonomy, 2022 to 2029
15.4.1. By Country
15.4.1.1. Germany
15.4.1.2. Italy
15.4.1.3. France
15.4.1.4. The UK
15.4.1.5. Spain
15.4.1.6. BENELUX
15.4.1.7. Russia
15.4.1.8. Rest of Europe
15.4.2. By Product Type
15.4.3. By Application
15.4.4. By End User
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Product Type
15.5.3. By Application
15.5.4. By End User
15.6. Drivers and Restraints - Impact Analysis
16. South Asia Market Analysis 2014 to 2021 and Forecast 2022 to 2029
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2014 to 2021
16.4. Market Size (US$ Million) Forecast By Market Taxonomy, 2022 to 2029
16.4.1. By Country
16.4.1.1. India
16.4.1.2. Thailand
16.4.1.3. Indonesia
16.4.1.4. Malaysia
16.4.1.5. Rest of South Asia
16.4.2. By Product Type
16.4.3. By Application
16.4.4. By End User
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Product Type
16.5.3. By Application
16.5.4. By End User
16.6. Drivers and Restraints - Impact Analysis
17. East Asia Market Analysis 2014 to 2021 and Forecast 2022 to 2029
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2014 to 2021
17.4. Market Size (US$ Million) Forecast By Market Taxonomy, 2022 to 2029
17.4.1. By Country
17.4.1.1. China
17.4.1.2. Japan
17.4.1.3. South Korea
17.4.2. By Product Type
17.4.3. By Application
17.4.4. By End User
17.5. Market Attractiveness Analysis
17.5.1. By Country
17.5.2. By Product Type
17.5.3. By Application
17.5.4. By End User
17.6. Drivers and Restraints - Impact Analysis
18. Oceania Market Analysis 2014 to 2021 and Forecast 2022 to 2029
18.1. Introduction
18.2. Pricing Analysis
18.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2014 to 2021
18.4. Market Size (US$ Million) Forecast By Market Taxonomy, 2022 to 2029
18.4.1. By Country
18.4.1.1. Australia
18.4.1.2. New Zealand
18.4.2. By Product Type
18.4.3. By Application
18.4.4. By End User
18.5. Market Attractiveness Analysis
18.5.1. By Country
18.5.2. By Product Type
18.5.3. By Application
18.5.4. By End User
18.6. Drivers and Restraints - Impact Analysis
19. Middle East and Africa Market Analysis 2014 to 2021 and Forecast 2022 to 2029
19.1. Introduction
19.2. Pricing Analysis
19.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2014 to 2021
19.4. Market Size (US$ Million) Forecast By Market Taxonomy, 2022 to 2029
19.4.1. By Country
19.4.1.1. GCC Countries
19.4.1.2. Turkey
19.4.1.3. Northern Africa
19.4.1.4. South Africa
19.4.1.5. Rest of Middle East and Africa
19.4.2. By Product Type
19.4.3. By Application
19.4.4. By End User
19.5. Market Attractiveness Analysis
19.5.1. By Country
19.5.2. By Product Type
19.5.3. By Application
19.5.4. By End User
19.6. Drivers and Restraints - Impact Analysis
20. Market Structure Analysis
20.1. Market Concentration
20.2. Market Share Analysis of Top Players
21. Competition Analysis
21.1. Competition Dashboard
21.2. Competition Deep Dive
21.2.1. Medtronic Plc
21.2.1.1. Overview
21.2.1.2. Product Portfolio
21.2.1.3. Profitability by Market Segments (Product / Channel / Region)
21.2.1.4. Strategy Overview
21.2.1.4.1. Marketing Strategy
21.2.1.4.2. Product Strategy
21.2.1.4.3. Channel Strategy
21.2.2. Merit Medical Systems
21.2.2.1. Overview
21.2.2.2. Product Portfolio
21.2.2.3. Profitability by Market Segments (Product / Channel / Region)
21.2.2.4. Strategy Overview
21.2.2.4.1. Marketing Strategy
21.2.2.4.2. Product Strategy
21.2.2.4.3. Channel Strategy
21.2.3. Biosense Webster, Inc
21.2.3.1. Overview
21.2.3.2. Product Portfolio
21.2.3.3. Profitability by Market Segments (Product / Channel / Region)
21.2.3.4. Strategy Overview
21.2.3.4.1. Marketing Strategy
21.2.3.4.2. Product Strategy
21.2.3.4.3. Channel Strategy
21.2.4. Teleflex Incorporated
21.2.4.1. Overview
21.2.4.2. Product Portfolio
21.2.4.3. Profitability by Market Segments (Product / Channel / Region)
21.2.4.4. Strategy Overview
21.2.4.4.1. Marketing Strategy
21.2.4.4.2. Product Strategy
21.2.4.4.3. Channel Strategy
21.2.5. Boston Scientific Corporation
21.2.5.1. Overview
21.2.5.2. Product Portfolio
21.2.5.3. Profitability by Market Segments (Product / Channel / Region)
21.2.5.4. Strategy Overview
21.2.5.4.1. Marketing Strategy
21.2.5.4.2. Product Strategy
21.2.5.4.3. Channel Strategy
21.2.6. Biomerics LLC
21.2.6.1. Overview
21.2.6.2. Product Portfolio
21.2.6.3. Profitability by Market Segments (Product / Channel / Region)
21.2.6.4. Strategy Overview
21.2.6.4.1. Marketing Strategy
21.2.6.4.2. Product Strategy
21.2.6.4.3. Channel Strategy
21.2.7. OSYPKA AG
21.2.7.1. Overview
21.2.7.2. Product Portfolio
21.2.7.3. Profitability by Market Segments (Product / Channel / Region)
21.2.7.4. Strategy Overview
21.2.7.4.1. Marketing Strategy
21.2.7.4.2. Product Strategy
21.2.7.4.3. Channel Strategy
21.2.8. Abbott
21.2.8.1. Overview
21.2.8.2. Product Portfolio
21.2.8.3. Profitability by Market Segments (Product / Channel / Region)
21.2.8.4. Strategy Overview
21.2.8.4.1. Marketing Strategy
21.2.8.4.2. Product Strategy
21.2.8.4.3. Channel Strategy
21.2.9. Japan Lifeline Co.
21.2.9.1. Overview
21.2.9.2. Product Portfolio
21.2.9.3. Profitability by Market Segments (Product / Channel / Region)
21.2.9.4. Strategy Overview
21.2.9.4.1. Marketing Strategy
21.2.9.4.2. Product Strategy
21.2.9.4.3. Channel Strategy
21.2.10. CathRx Ltd
21.2.10.1. Overview
21.2.10.2. Product Portfolio
21.2.10.3. Profitability by Market Segments (Product / Channel / Region)
21.2.10.4. Strategy Overview
21.2.10.4.1. Marketing Strategy
21.2.10.4.2. Product Strategy
21.2.10.4.3. Channel Strategy
21.2.11. Biotronik SE & Co. KG.
21.2.11.1. Overview
21.2.11.2. Product Portfolio
21.2.11.3. Profitability by Market Segments (Product / Channel / Region)
21.2.11.4. Strategy Overview
21.2.11.4.1. Marketing Strategy
21.2.11.4.2. Product Strategy
21.2.11.4.3. Channel Strategy
22. Assumptions and Acronyms Used
23. Research Methodology
Explore Healthcare Insights
View Reports
Deflectable Catheters Market
